[go: up one dir, main page]

NI200300001A - Comprimido de nelfinavir de dosis incrementada y metodo para fabricarlo. - Google Patents

Comprimido de nelfinavir de dosis incrementada y metodo para fabricarlo.

Info

Publication number
NI200300001A
NI200300001A NI200300001A NI200300001A NI200300001A NI 200300001 A NI200300001 A NI 200300001A NI 200300001 A NI200300001 A NI 200300001A NI 200300001 A NI200300001 A NI 200300001A NI 200300001 A NI200300001 A NI 200300001A
Authority
NI
Nicaragua
Prior art keywords
nelfinavir
compressed dosage
mixture
increased manufacture
mechanical energy
Prior art date
Application number
NI200300001A
Other languages
English (en)
Spanish (es)
Inventor
Grace Chen
James Leo Gallagher
Yosyong Surakitbanharn
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NI200300001A publication Critical patent/NI200300001A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glanulating (AREA)
NI200300001A 2002-01-28 2003-01-07 Comprimido de nelfinavir de dosis incrementada y metodo para fabricarlo. NI200300001A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35142002P 2002-01-28 2002-01-28

Publications (1)

Publication Number Publication Date
NI200300001A true NI200300001A (es) 2004-12-21

Family

ID=27663002

Family Applications (1)

Application Number Title Priority Date Filing Date
NI200300001A NI200300001A (es) 2002-01-28 2003-01-07 Comprimido de nelfinavir de dosis incrementada y metodo para fabricarlo.

Country Status (23)

Country Link
EP (1) EP1469836A1 (zh)
JP (1) JP2005521661A (zh)
KR (1) KR20040079952A (zh)
CN (1) CN1713895A (zh)
AR (1) AR038236A1 (zh)
BR (1) BR0307190A (zh)
CA (1) CA2398226A1 (zh)
GT (1) GT200300016A (zh)
HN (1) HN2003000048A (zh)
HU (1) HUP0500512A2 (zh)
IL (1) IL162724A0 (zh)
MX (1) MXPA04007237A (zh)
NI (1) NI200300001A (zh)
NO (1) NO20043238L (zh)
NZ (1) NZ533283A (zh)
PA (1) PA8564301A1 (zh)
PE (1) PE20030730A1 (zh)
PL (1) PL373882A1 (zh)
RU (1) RU2004123206A (zh)
SV (1) SV2004001467A (zh)
TW (1) TW200302111A (zh)
WO (1) WO2003063837A1 (zh)
ZA (1) ZA200404367B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008053276A1 (en) * 2006-10-30 2008-05-08 Collette Nv Transition piece for the transfer of powder or granular material from a discharge opening to a conveying line and method of transferring powder or granular material
AU2007358602A1 (en) * 2007-09-03 2009-03-12 Lucent Technologies Inc. Method and system for checking automatically connectivity status of an IP link on IP network

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6499984B1 (en) * 2000-05-22 2002-12-31 Warner-Lambert Company Continuous production of pharmaceutical granulation
MXPA03009971A (es) * 2001-05-03 2004-02-12 Hoffmann La Roche FORMA DE DOSIFICACIoN FARMACEUTICA DE MESILATO DE NELFINAVIR AMORFO.

Also Published As

Publication number Publication date
NO20043238L (no) 2004-08-02
CA2398226A1 (en) 2003-07-28
RU2004123206A (ru) 2005-04-20
PA8564301A1 (es) 2003-09-05
GT200300016A (es) 2003-09-11
HUP0500512A2 (hu) 2005-09-28
HN2003000048A (es) 2003-10-28
KR20040079952A (ko) 2004-09-16
WO2003063837A1 (en) 2003-08-07
CN1713895A (zh) 2005-12-28
IL162724A0 (en) 2005-11-20
AR038236A1 (es) 2005-01-05
BR0307190A (pt) 2004-11-03
JP2005521661A (ja) 2005-07-21
PL373882A1 (en) 2005-09-19
MXPA04007237A (es) 2004-10-29
NZ533283A (en) 2006-12-22
ZA200404367B (en) 2006-05-31
TW200302111A (en) 2003-08-01
EP1469836A1 (en) 2004-10-27
SV2004001467A (es) 2004-05-07
PE20030730A1 (es) 2003-08-28

Similar Documents

Publication Publication Date Title
CY1108973T1 (el) Ξηρα κοκκοποιημενη συνθεση η οποια περιλαμβανει εμτρισιταβινη και τενοφοβιρη df
BRPI0613754B8 (pt) compostos, éster de um composto, composições farmacêuticas que compreendem o composto, método para o tratamento terapêutico e/ou profilático de enfermidades que são moduladas por análogos de hormônio de tireóide e utilização dos compostos
AR051618A1 (es) Comprimido bicapa y metodo
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
BRPI0707044B8 (pt) comprimido matricial insolúvel em água e processo de fabricação de comprimidos matriciais
ECSP077999A (es) Formulaciones de una sal de bupropion de liberación modificada
CL2015001891A1 (es) Formas de dosis de liberación controlada encerradas resistentes a manipulaciones indebidas; uso para tratar el dolor; y metodo de preparacion. (divisional de la solicitud n°2754-2014).
ECSP099320A (es) Compuestos de tetrahidropirrolopiracina sustituida y su aplicación en medicamentos
NO20084065L (no) Hurtig frigivelses paracetamol tabletter
AR038527A1 (es) Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
ES2091142T3 (es) Amilosa reticulada como aglomerante/disgregante en comprimidos.
EA201691322A1 (ru) Фармацевтическая композиция ингибитора dpp-iv в комбинации с метформином
NO20074109L (no) Intravenose formuleringer av PDE-5 inhibitorer
DOP2002000389A (es) Metodo para fabricar una composición farmaceutica de dosis baja que tiene una distribución y potencia del fármaco uniforme
AR077284A1 (es) Composiciones de dosis fija farmaceuticas solidas que comprenden irbesartan y amlodipina, su preparacion y su aplicacion terapeutica
CY1122114T1 (el) Καταπινομενα δισκια ν-ακετυλοκυστεϊνης
CO6640264A2 (es) Combinación de gránulos cargados activos con activos adicionales
NI200300001A (es) Comprimido de nelfinavir de dosis incrementada y metodo para fabricarlo.
AR080256A1 (es) Formulaciones farmaceuticas solidas de ramipril y besilato de amlodipino y su preparacion
UY27625A1 (es) Comprimido de nelfinavir de dosis incrementada y método para fabricarlo
DOP2003000567A (es) Comprimido de nelfinavir de dosis incrementada y metodo para fabricarlo
MXPA02010828A (es) Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
BRPI0407850A (pt) processo para fabricação de uma composição farmacêutica contendo o princìpio ativo fenofibrato ou de um de seus derivados, e, comprimido de fenofibrato ou de um de seus derivados
TR200102802T2 (tr) Tabletlerin direk kompresyonla üretiminde, yüksek L-karnitin-alkanoil L-karnitinli granülat
AR027058A1 (es) Bases pirrolicas sustituidas de mannich, procedimiento para su preparacion, medicamentos que contienen compuestos y uso de estos compuestos para lapreparacion de medicamentos